Literature DB >> 15901784

Endogenous kappa-opioid receptor systems regulate mesoaccumbal dopamine dynamics and vulnerability to cocaine.

John E Pintar1, Toni S Shippenberg2, Vladimir I Chefer2, Traci Czyzyk1, Elizabeth A Bolan2, Jose Moron2.   

Abstract

Genetic and pharmacological approaches were used to examine kappa-opioid receptor (KOR-1) regulation of dopamine (DA) dynamics in the nucleus accumbens and vulnerability to cocaine. Microdialysis revealed that basal DA release and DA extraction fraction (Ed), an indirect measure of DA uptake, are enhanced in KOR-1 knock-out mice. Analysis of DA uptake revealed a decreased Km but unchanged Vmax in knock-outs. Knock-out mice exhibited an augmented locomotor response to cocaine, which did not differ from that of wild-types administered a behavioral sensitizing cocaine treatment. The ability of cocaine to increase DA was enhanced in knock-outs, whereas c-fos induction was decreased. Although repeated cocaine administration to wild types produced behavioral sensitization, knock-outs exhibited no additional enhancement of behavior. Administration of the long-acting KOR antagonist nor-binaltorphimine to wild-type mice increased DA dynamics. However, the effects varied with the duration of KOR-1 blockade. Basal DA release was increased whereas Ed was unaltered after 1 h blockade. After 24 h, release and Ed were increased. The behavioral and neurochemical effects of cocaine were enhanced at both time points. These data demonstrate the existence of an endogenous KOR-1 system that tonically inhibits mesoaccumbal DA neurotransmission. Its loss induces neuroadaptations characteristic of "cocaine-sensitized" animals, indicating a critical role of KOR-1 in attenuating responsiveness to cocaine. The increased DA uptake after pharmacological inactivation or gene deletion highlights the plasticity of mesoaccumbal DA neurons and suggests that loss of KOR-1 and the resultant disinhibition of DA neurons trigger short- and long-term DA transporter adaptations that maintain normal DA levels, despite enhanced release.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15901784      PMCID: PMC1405843          DOI: 10.1523/JNEUROSCI.0854-05.2005

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  33 in total

1.  The use of microdialysis in the mouse: conventional versus quantitative techniques.

Authors:  T S Shippenberg; M He; V Chefer
Journal:  Psychopharmacology (Berl)       Date:  1999-11       Impact factor: 4.530

2.  U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking.

Authors:  S Schenk; B Partridge; T S Shippenberg
Journal:  Psychopharmacology (Berl)       Date:  1999-06       Impact factor: 4.530

Review 3.  Incentive-sensitization and addiction.

Authors:  T E Robinson; K C Berridge
Journal:  Addiction       Date:  2001-01       Impact factor: 6.526

Review 4.  Modulation of the behavioral and neurochemical effects of psychostimulants by kappa-opioid receptor systems.

Authors:  T S Shippenberg; V I Chefer; A Zapata; C A Heidbreder
Journal:  Ann N Y Acad Sci       Date:  2001-06       Impact factor: 5.691

Review 5.  Addiction.

Authors:  Terry E Robinson; Kent C Berridge
Journal:  Annu Rev Psychol       Date:  2002-06-10       Impact factor: 24.137

Review 6.  Pharmacotherapy of addictions.

Authors:  Mary Jeanne Kreek; K Steven LaForge; Eduardo Butelman
Journal:  Nat Rev Drug Discov       Date:  2002-09       Impact factor: 84.694

Review 7.  Cocaine sensitization and craving: differing roles for dopamine and glutamate in the nucleus accumbens.

Authors:  J L Cornish; P W Kalivas
Journal:  J Addict Dis       Date:  2001

8.  Major coexpression of kappa-opioid receptors and the dopamine transporter in nucleus accumbens axonal profiles.

Authors:  A L Svingos; C Chavkin; E E Colago; V M Pickel
Journal:  Synapse       Date:  2001-12-01       Impact factor: 2.562

9.  Kappa-opioid receptor activation modifies dopamine uptake in the nucleus accumbens and opposes the effects of cocaine.

Authors:  A C Thompson; A Zapata; J B Justice; R A Vaughan; L G Sharpe; T S Shippenberg
Journal:  J Neurosci       Date:  2000-12-15       Impact factor: 6.167

10.  The dopamine D1 receptor is a critical mediator for cocaine-induced gene expression.

Authors:  Dongsheng Zhang; Lu Zhang; Dan Wen Lou; Yusaku Nakabeppu; Jianhua Zhang; Ming Xu
Journal:  J Neurochem       Date:  2002-09       Impact factor: 5.372

View more
  76 in total

1.  Basolateral amygdala-driven augmentation of medial prefrontal cortex GABAergic neurotransmission in response to environmental stimuli associated with cocaine administration.

Authors:  Vladimir I Chefer; Ruizhong Wang; Toni S Shippenberg
Journal:  Neuropsychopharmacology       Date:  2011-06-01       Impact factor: 7.853

Review 2.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

Review 3.  The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity.

Authors:  Gregory M Miller
Journal:  J Neurochem       Date:  2011-01       Impact factor: 5.372

4.  The κ-opioid receptor gene as a predictor of response in a cocaine vaccine clinical trial.

Authors:  David A Nielsen; Sara C Hamon; Thomas R Kosten
Journal:  Psychiatr Genet       Date:  2013-12       Impact factor: 2.458

5.  Repeated exposure to moderate doses of ethanol augments hippocampal glutamate neurotransmission by increasing release.

Authors:  Vladimir Chefer; Jennifer Meis; Grace Wang; Alexander Kuzmin; Georgy Bakalkin; Toni Shippenberg
Journal:  Addict Biol       Date:  2010-12-23       Impact factor: 4.280

6.  Kappa opioid inhibition of somatodendritic dopamine inhibitory postsynaptic currents.

Authors:  Christopher P Ford; Michael J Beckstead; John T Williams
Journal:  J Neurophysiol       Date:  2006-11-22       Impact factor: 2.714

7.  Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location.

Authors:  Christopher P Ford; Gregory P Mark; John T Williams
Journal:  J Neurosci       Date:  2006-03-08       Impact factor: 6.167

8.  Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion.

Authors:  Antony D Abraham; Selena S Schattauer; Kathryn L Reichard; Joshua H Cohen; Harrison M Fontaine; Allisa J Song; Salina D Johnson; Benjamin B Land; Charles Chavkin
Journal:  J Neurosci       Date:  2018-08-03       Impact factor: 6.167

Review 9.  Molecular and genetic substrates linking stress and addiction.

Authors:  Lisa A Briand; Julie A Blendy
Journal:  Brain Res       Date:  2009-11-10       Impact factor: 3.252

10.  Kappa Opioid Receptor-Mediated Disruption of Novel Object Recognition: Relevance for Psychostimulant Treatment.

Authors:  Jason J Paris; Kate J Reilley; Jay P McLaughlin
Journal:  J Addict Res Ther       Date:  2011-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.